Clinical trial
Median Effective Dose of Lidocaine for the Prevention of Pain Caused by the Injection of Propofol Formulated With Medium-/Long-chain Triglycerides
NCT04008433 is registered in ClinicalTrials.gov with Yangzhou University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Median Effective Dose of Lidocaine for the Prevention of Pain Caused by the Injection of Propofol Formulated With Medium-/Long-chain Triglycerides
- Lead sponsor
- Yangzhou University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 16, 2018
- Completion date
- June 13, 2019
- Enrollment
- 31 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
injection pain, lidocaine